Posted by AGORACOM-JC
at 8:35 AM on Thursday, December 3rd, 2020
We all remember the crash of “blockchain” smallcap stocks a couple of years back, which was actually a crash of blockchain pretenders who used the term to build stock promotions, as opposed to building actual blockchains.
Like the dot-com crash of 2000, which bankrupted “dot-com” companies but gave birth to the likes of Google, Amazon, Linkedin because they built actual utility and value, the same can be expected of the blockchain crash and its resurgence.
Blockchain Foundry is a “Blockchain 2.0” company that has survived and is thriving. More than just lip service, take a look at the following highlights:
Revenue for 9 months of 2020 (ending Sept 30) ~$1.1M
113% Year Over Year Growth
Net Income $140,000 = $610,000 Improvement
Completed development agreement with a large Canadian financial institution valued at approximately C$400,000;
Partnered with Binance, the largest digital asset trading platform in the world, to leverage the Syscoin platform.
5 Active Clients + Robust Pipeline
Conclusion – BCFN is a smallcap Blockchain company with Real Customers, Real Revenues and Real Income
Watch this interview with Dan Wasyluk, CEO of Blockchain Foundry
Posted by AGORACOM-JC
at 10:04 PM on Wednesday, December 2nd, 2020
Facebook and other tech giants showed the world that sharing our private data and profiting from it is a major issue. It became such a major issue that sweeping laws have been enacted in Europe (GDPR) and the United States (CCPA) that not only puts a stop to these practices but also demand that individuals are given the opportunity to take control of their digital identities – and even profit from them.
The term is often referred to as “Self Sovereign Identity (SSI)” and though it sounds kind of complicated, it actually sounds like music to the ears of investors that want to learn more about this massive global trend.
KABN is the small cap company that is leaps and bounds ahead of any other small cap company in this space. Their technology is damn cool (check out www.LiquidAvatar.com) and their global recognition is even better given their recent addition to the Trust Over IP Foundation as a Steering Member, joining the likes of IBM, Mastercard, Accenture and other global giants that are forming an ecosystem around SSI
This is a global paradigm shift that you DO NOT want to miss because it is happening right now and KABN is the leading small cap company for investors to gain exposure.
Watch this powerful interview with KABN CEO David Lucatch.
Posted by AGORACOM-JC
at 4:31 PM on Wednesday, November 25th, 2020
PyroGenesis (PYR:TSX) recently UP-Listed to the TSX from the TSX Venture on the strength of some major sales agreements for its plasma torch technology. Specifically, PYR announced an $11.5M sales to the US Navy for systems on two aircraft carriers, as well as, a $25M + contract for use by one of the biggest high-tech aluminum smelters in the world.
Yesterday, PYR announced the signing of an initial plasma torch contract with a Major Iron Ore Producer. The initial sale amount of $1.8M (for just 1 unit) doesn’t come close to the size of the agreements above – but it follows the exact same game plan of starting small and finishing big, something the Company alluded to in the press release quote which stated the following;
“It is expected that future sales with this Client will include a separate continued after-sale services agreement. The Client is a multi-billion-dollar international producer of iron ore pellets, one of the largest in the industry, whose name will remain confidential for competitive reasons. The Client, which has committed to reduce its greenhouse gas (“GHG”) emissions, has over ten (10) plants, each possibly requiring up to 50 plasma torches.”
The math has not alluded investors, who first had a slew of their own questions which CEO Peter Pascali answered as part of this great interview.
Posted by AGORACOM-JC
at 5:16 PM on Thursday, November 19th, 2020
2020 has been a disappointing one for the once euphoric cannabis industry thanks to the fallout of over-hyped and over-financed companies that failed to deliver on a fraction of their promises.
The year 2000 saw the exact same thing happen to “dot-com” companies that failed in even more spectacular fashion. Many investors swore off internet stocks forever.
The smart ones waited to see which companies were real … and the rest was history as we saw the birth and growth of internet companies that delivered real value, products and customers.
The same is about to happen in the Cannabis space. With the market estimated to hit $70 Billion over the next few years, there is very little doubt that winners will be created out of companies delivering real businesses.
Enter Innocan Pharma Corporation (INNO:CSE) (IP4: FSE) and it’s incredible team of accomplished scientists led by CEO Iris Bincovich.
As a Cannabis investor, why limit yourself to a Company with just one specialty, when InnoCan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products, the latter of which have already announced distribution and manufacturing agreements throughout Europe and the United States.
If you believe in the future of the cannabis and companies delivering real, value-add CBD products, then watch this interview with Innocan CEO, Iris Bincovich.
Posted by AGORACOM-JC
at 5:04 PM on Wednesday, November 18th, 2020
ThreeD Capital (IDK:CSE / IDKFF:OTCQB) prides itself on discovering great companies before everyone else … and it casts a wide net to find the best of the best ranging from precious metals companies to completely disruptive companies. Moreover, IDK isn’t afraid to invest and be patient in both public and private companies.
As such, it’s like and ETF for ground floor investments that small cap investors would either be unable to find (private) or unable to participate in (early round accredited investors)
It is able to do all this and do it well under the leadership of one of the greatest investors in Canadian history – Sheldon Inwentash, the Founder, Chairman and CEO of IDK. Inwentash’s track record of success speaks for itself, including successful exits in the hundreds of millions and even billions in previous years. His last company commanded a market cap north of $1 Billion and now he’s looking to create another success out of IDK.
Will he do it? He’s off to a good start so far by quietly making investments over the past couple of years that are now starting to pay off. In this interview Inwentash discusses:
His investment philosophy
A couple of his recent investments in Peak Fintech (PKK:CSE) and Loop Insights (MTRX:TSXV)
Why he’s investing heavily in gold juniors
Why he’s investing heavily in blockchain companies + their tokens
Best of all, after one hell of a ride for the financial markets in 2020, Inwentash talks about why 2021 “is the year to be all in”
Watch this great interview … because when a legendary financier speaks, every small cap investor should be listening.
Posted by AGORACOM-JC
at 12:39 PM on Wednesday, November 18th, 2020
Avicanna (AVCN: TSX) (AVCN: OTCQX) (0NN: FSE) is a vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global marketplace.
Third Quarter Highlights
$882K in revenue, an increase of 24% from Q2-2020,
Double-digit growth quarter over quarter from Q4-2019
Reached a major milestone with the launch of certain products from its RHO Phyto product line in Canada and further diversified its revenue streams.
When we say vertically integrated, we mean it. Avicanna has 4 fully operating divisions to address the entire market for Cannabis products as follows:
1. The company has a full line of high end CBD based skin care products serving the consumer retail segment with Canadian distribution through Medical Cannabis by Shoppers, as well as global distribution later this year.
2. Avicanna’s superior medical cannabis line also features products distributed through Medical Cannabis by Shoppers, the online arm of Canada’s largest drugstore chain. In addition, the company recently received certification and authorization for the sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia.
3. Avicanna also hosts a full pipeline of Pharmaceuticals in various stages of trials to address Dermatology, Psychiatry, Neurology, Pain and Oncology. Three of the company’s products are already as far as phase 2.
Posted by AGORACOM-JC
at 8:25 PM on Sunday, November 15th, 2020
Sometimes, you just have to let the numbers speak for themselves. With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for … but then you see these numbers for the first half of the year:
Revenues $USD 1.7M vs $745,000 = 130% Gain
Patient Visits 12,400 vs 5,500 = 125% Gain
CBDT has now delivered growth in 4 successive financial reports (Q4, FY 2019, Q1 and Q2), so it is safe to say that superstar CEO Steve McAuley can officially claim victory on the turnaround he inherited in 2019.
Despite officially acquiring KAI on October 5th, Empower was able to walk right into KAI and increase testing volume by 763% sequentially (vs September) to 1,375 units. While most companies need a couple of months to really start making changes within the operations of new acquisitions, McAuley hit the ground running and even.
How much revenue was generated from these record October tests? CEO McAuley gives us back of the napkin math to play with.
But he is far from done.
Just as Empower did with their clinics, Empower has aggressive growth strategies in place for KAI, including servicing new COVID-19 testing contracts for the:
Film & television industry
Banks
Restaurants
Tourism and ….
Supporting the Sun Valley Health COVID-19 RT-PCR and rapid antibody testing programs in the state of Arizona.
One, some or all of these should lead to even bigger numbers in November. In fact, we asked him if he was “concerned” that he may run out of capacity of 4,000 tests per day (a great concern to have). Wait until you hear his answer.
But just one more thing
Empower announced it:
“has signed numerous new commercial testing contracts, the details of which will be provided in subsequent press releases.”
Somebody get out a calculator
It doesn’t take much to see that KAI has the potential to take Empower to a whole new level. Specifically, if you’re an investor in Well Health (WELL:TSX) and/or CloudMD (DOC:TSXV) you have to start taking a serious look at Empower as the next great potential health and wellness company. It’s already proven solid revenues and growth from its clinics, is expanding its telemedicine practice very nicely and now has the power to quickly generate significant enterprise level revenues from its newly acquired KAI medical diagnostics laboratory … which is already bearing fruit just 30 days after the acquisition.
Can McAuley pull it off? First consider what he has already accomplished after inheriting a catastrophe of a company in early 2019. Secondly, McAuley is Six Sigma certified under the quality initiative of legendary GE (General Electric) Chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into significant growth through Q2 2020.
And if you MISSED Well Health and CloudMD, you really need to take a close look at Empower as the next great potential small cap health & wellness company.
Posted by AGORACOM-JC
at 8:22 PM on Sunday, November 15th, 2020
How do you connect over 100M small businesses in China who need access to different kinds of credit …. with over 10K banks and lending institutions that have different lending criteria?
Well, if you try to do it the old fashioned way, you just can’t. SMB’s (small and medium businesses) and Lenders are pretty much forced to deal within local markets which drastically reduces alternatives and business …. and both sides are left with a daunting, slow and inefficient manual workload.
ENTER PEAK FINTECH
The Peak Fintech Lending Hub uses Artificial Intelligence and analytics to fully automate the process by which lenders and borrowers connect quickly and match perfectly across several market verticals.
When Joseph and Inwentash say this AI-Powered platform is revolutionizing the Chinese SMB commercial lending ecosystem, they’re not just paying lip service … Peak Fintech is delivering results
Reported revenue growth of 293% to $11.2 million for the first half of 2020
Targeting $40 million in revenues and $4 million in EBITDA for the 2020 year.
Platform now has lending products from 54 different banks and lending institutions
Signed Agreement To Bring Lending Hub To 60,000 Online Electronics Stores
Stores would use Lending HUB to finance purchase of electronics inventory
100% market capture would translate into $1.35B in annual revenues
Inwentash discusses what attracted him to PKK, what his interest is in the Company and what he sees for the Company’s future.
Joseph also discusses new government regulations in China since the Ant IPO was suspended and whether they would impact PKK, as well as, the Company’s growth outlook for 2021.
